We found 10 episodes of Oncology Today with Dr Neil Love with the tag “research to practice”.
-
Current and Future Management of Follicular Lymphoma with Dr Loretta Nastoupil
July 5th, 2022 | Season 1 | 42 mins 27 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the evolving therapeutic landscape in follicular lymphoma with Dr Loretta Nastoupil, moderated by Dr Neil Love.
-
Updates on Ovarian Cancer from SGO 2022 with Dr David O’Malley
May 4th, 2022 | Season 1 | 43 mins 32 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on ovarian cancer presentations from SGO 2022 with Dr David O’Malley, moderated by Dr Neil Love.
-
PARP Inhibitors in Breast Cancer with Dr Judy Garber
April 20th, 2022 | Season 1 | 39 mins 51 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of breast cancer with PARP inhibitors with Dr Judy Garber, moderated by Dr Neil Love.
-
Advances in Soft Tissue Sarcomas with Dr Mark Agulnik
March 14th, 2022 | Season 1 | 42 mins 35 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of soft tissue sarcoma with Dr Mark Agulnik, moderated by Dr Neil Love.
-
Key Presentations on Multiple Myeloma from ASH 2021 with Dr Ajai Chari
March 10th, 2022 | Season 1 | 40 mins 27 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of multiple myeloma from the 2021 ASH annual meeting with Dr Ajai Chari, moderated by Dr Neil Love.
-
Key Presentations on Advances in Myeloproliferative Neoplasms from ASH 2021 with Dr Prithviraj Bose
March 7th, 2022 | Season 1 | 40 mins 27 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of myeloproliferative neoplasms from the 2021 ASH annual meeting with Dr Prithviraj Bose, moderated by Dr Neil Love.
-
Advances in the Treatment of Hodgkin and Non-Hodgkin Lymphomas from ASH 2021 with Dr Matthew Lunning
February 21st, 2022 | Season 1 | 43 mins 30 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of Hodgkin and non-Hodgkin lymphomas with Dr Matthew Lunning, moderated by Dr Neil Love.
-
Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from ASH 2021
February 17th, 2022 | Season 1 | 40 mins 11 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on updates from the 2021 ASH annual meeting on the treatment of acute myeloid leukemia and myelodysplastic syndromes with Dr Andrew Brunner, moderated by Dr Neil Love.
-
Current Issues in the Research and Management of Localized Hormone Receptor-Positive Breast Cancer with Dr Sara Tolaney.
February 11th, 2022 | Season 1 | 39 mins 45 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on some of the current major issues in the management of ER-positive breast cancer with Dr Sara Tolaney, moderated by Dr Neil Love.
-
Recent Advances in the Treatment of Chronic Lymphocytic Leukemia with Dr Peter Hillmen
February 9th, 2022 | Season 1 | 40 mins 1 sec
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the management of chronic lymphocytic leukemia with Dr Peter Hillmen, moderated by Dr Neil Love.